Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18 per share, or 6.9% [6]. - Following the release of Q3 2025 financial results on November 20, 2025, the company announced further cuts to its full year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22 per share, or 24.8% [7]. Legal Proceedings - Investors have until March 16, 2026, to request to be appointed to lead the class action case, which is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al. [3].

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  The class action concerns whether Bath & Body ...

The lead plaintiff deadline is March 13, 2026. RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works†) (NYSE: BBWI) on behalf of those who purchased or otherwise acquired Bath & Body Works securities between June 4, 2024, and November 19, 2025, inclusive (the "Class Period†). The complaint alleges that, throughout the Class Period, De ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was effective in driving topline growth [5]. Group 3: Stock Performance and Financial Results - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements and failure to disclose critical information regarding the company's financial performance and strategies [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its business strategies and financial results during the Class Period [5]. - Allegations include that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [5]. - The lawsuit asserts that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, leading to a failure to meet previously issued financial guidance [5]. Group 2: Participation Information - Investors who purchased Bath & Body Works securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the Court by March 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the Q3 2025 financial results on November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Context - Investors have until March 16, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements regarding its performance and strategies [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from June 4, 2024, to November 19, 2025, with a deadline for lead plaintiff appointments set for March 16, 2026 [2]. - The complaint alleges that Bath & Body Works' strategy of "adjacencies, collaborations and promotions" did not lead to sales growth or improved customer metrics, and that the company used brand collaborations to obscure its poor performance [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although such an appointment is not necessary to participate in any recovery [2].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. for alleged material misstatements and omissions affecting investors who purchased securities between June 4, 2024, and November 19, 2025 [1][5]. Group 1: Allegations - The lawsuit claims that Bath & Body Works made materially false and misleading statements regarding its business strategy and financial performance during the Class Period [2]. - Specifically, it is alleged that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [2]. - The complaint further asserts that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, leading to an inability to meet previously issued financial guidance [2]. Group 2: Legal Process - Investors affected by the alleged fraud can seek to be appointed as lead plaintiffs by March 13, 2026, through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - The lead plaintiff will represent the interests of all class members in directing the litigation and selecting counsel [3]. Group 3: Firm Information - Kessler Topaz Meltzer & Check, LLP is a prominent law firm specializing in securities fraud class actions and represents both individual and institutional investors [5][6]. - The firm has a history of significant recoveries in securities litigation and has received various accolades for its work in this field [6].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements made by the company regarding its business strategy and financial performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its growth strategy, which failed to deliver the expected results [5]. - The lawsuit alleges that the company's reliance on brand collaborations to mask weak financial results led to a failure to meet previously issued financial guidance [5]. - Investors are encouraged to join the class action to seek compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has a history of significant recoveries for investors, including over $438 million secured in 2019 alone [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].